Di Lorenzo Antonio, Triggiano Francesco, Lopuzzo Marco, Piccolomo Luigi, Triggiani Marco, Grasso Salvatore, Stefanizzi Pasquale, Tafuri Silvio, Dalfino Lidia, Caggiano Giuseppina
Interdisciplinary Department of Medicine, Hygiene Unit, University of Bari Aldo Moro, Bari, Italy.
Department of Emergency and Organ Transplantation, Anesthesia and Intensive Care Unit, University of Bari Aldo Moro, Bari, Italy.
IJID Reg. 2024 Oct 9;13:100468. doi: 10.1016/j.ijregi.2024.100468. eCollection 2024 Dec.
has been circulating since 2019 in Northern and Middle-Italy regions.
This report details the first three cases of isolation in Puglia (Southern Italy), which occurred as a nosocomial outbreak.
The first specimen was isolated on April 19, 2024 from a blood culture obtained from a 55-year-old male (GM) in an intensive care unit (ICU) of Bari Policlinico General Hospital. The patient had been admitted on April 06, 2024 due to subarachnoid hemorrhage. On April 12, 2024, a blood sample tested positive for multidrug-resistant , requiring isolation and wide-spectrum antibiotic therapy. Exitus occurred on April 17, 2024, but 2 days later, a pre-mortem blood sample tested positive for , leading to epidemiologic investigation in the whole ICU.A second case was therefore identified (SD), a 36-year-old male admitted on March 21, 2024, shortly after undergoing a dental procedure in Tirana (Albania). Due to the timing of admission, he was identified as the index case.A third case was later found on April 29, 2024 (CM), a 52-year-old woman with a history of acute myeloid leukemia located in the same ICU but on a different floor.A link of transmission was identified via environmental sampling, as the medics' common telephone tested positive for contamination.
The pathogen's circulation has shown to be inapparent and difficult to track, making it a potential threat even for facilities outside of known high-risk geographical areas. ICUs should be monitored routinely.
自2019年以来一直在意大利北部和中部地区传播。
本报告详细介绍了普利亚(意大利南部)的前三例隔离病例,这些病例是作为医院内暴发出现的。
第一份样本于2024年4月19日从巴里综合医院重症监护病房(ICU)一名55岁男性(GM)的血培养物中分离出来。该患者因蛛网膜下腔出血于2024年4月6日入院。2024年4月12日,一份血样检测出多重耐药菌呈阳性,需要隔离并进行广谱抗生素治疗。患者于2024年4月17日死亡,但两天后,一份死前血样检测出该菌呈阳性,从而在整个ICU展开了流行病学调查。因此确定了第二例病例(SD),一名36岁男性,于2024年3月21日在阿尔巴尼亚地拉那接受牙科手术后不久入院。由于入院时间,他被确定为索引病例。第三例病例于2024年4月29日被发现(CM),是一名52岁女性,有急性髓系白血病病史,位于同一ICU但不同楼层。通过环境采样确定了传播链,因为医护人员共用的电话检测出该菌污染呈阳性。
病原体的传播已显示出不明显且难以追踪特性,即使对已知高风险地理区域以外的设施也构成潜在威胁。应对重症监护病房进行常规监测。